Knowledge of body site variability in ultraviolet-induced erythemal responses guides choice of site for pre-therapy minimal erythema dose testing.
Dawe
Robert S
RS
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D004890:Erythema / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D012880:Skin Pigmentation / Q000528:radiation effects*; D014466:Ultraviolet Rays / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents